Details for Patent: 10,829,465
✉ Email this page to a colleague
Which drugs does patent 10,829,465 protect, and when does it expire?
Patent 10,829,465 protects HETLIOZ and HETLIOZ LQ and is included in two NDAs.
This patent has nine patent family members in three countries.
Summary for Patent: 10,829,465
Title: | Highly purified pharmaceutical grade tasimelteon |
Abstract: | A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities. |
Inventor(s): | Phadke; Deepak (Olathe, KS), Platt; Natalie M. (Columbia, MD), Pandrapragada; Ravi K. (Clarksburg, MD) |
Assignee: | VANDA PHARMACEUTICALS INC. (Washington, DC) |
Application Number: | 16/800,721 |
Patent Claim Types: see list of patent claims | Composition; Compound; Process; |
Drugs Protected by US Patent 10,829,465
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Vanda Pharms Inc | HETLIOZ LQ | tasimelteon | SUSPENSION;ORAL | 214517-001 | Dec 1, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,829,465
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 3105212 | ⤷ Try a Trial | |||
European Patent Office | 3470405 | ⤷ Try a Trial | |||
European Patent Office | 4223747 | ⤷ Try a Trial | |||
Japan | 2017506642 | ⤷ Try a Trial | |||
Japan | 2020079248 | ⤷ Try a Trial | |||
Japan | 2022088624 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |